{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:37:36Z","timestamp":1761975456198},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2015,5,10]],"date-time":"2015-05-10T00:00:00Z","timestamp":1431216000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1007\/s00115-015-4305-x","type":"journal-article","created":{"date-parts":[[2015,5,8]],"date-time":"2015-05-08T08:01:29Z","timestamp":1431072089000},"page":"989-996","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Stammzelltransplantation bei Multipler Sklerose"],"prefix":"10.1007","volume":"86","author":[{"given":"J.-P.","family":"Stellmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.H.","family":"St\u00fcrner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Ufer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Havemeister","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"P\u00f6ttgen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Ayuk Ayuketang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Kr\u00f6ger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.A.","family":"Friese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Heesen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,5,10]]},"reference":[{"key":"4305_CR1","doi-asserted-by":"crossref","unstructured":"Reston JT, Uhl S, Treadwell JR et al (2010) Autologous hematopoietic cell transplantation for multiple sclerosis: a systematic review. Mult Scler. doi:10.1177\/1352458510383609","DOI":"10.1177\/1352458510383609"},{"key":"4305_CR2","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s13311-012-0162-5","volume":"10","author":"Atkins","year":"2013","unstructured":"Atkins HL, Freedman MS (2013) Hematopoietic stem cell therapy for multiple sclerosis: top 10 lessons learned. Neurotherapeutics 10:68\u201376. doi:10.1007\/s13311-012-0162-5","journal-title":"Neurotherapeutics"},{"key":"4305_CR3","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1177\/1352458512438454","volume":"18","author":"Saccardi","year":"2012","unstructured":"Saccardi R, Freedman MS, Sormani MP et al (2012) A prospective, randomized, controlled trial of autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: a position paper. Mult Scler 18:825\u2013834. doi:10.1177\/1352458512438454","journal-title":"Mult Scler"},{"key":"4305_CR4","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1212\/WNL.0000000000001329","volume":"84","author":"Mancardi","year":"2015","unstructured":"Mancardi GL, Sormani MP, Gualandi F et al (2015) Autologous hematopoietic stem cell transplantation in multiple sclerosis A phase II trial. Neurology 84(10):981\u2013988","journal-title":"Neurology"},{"key":"4305_CR5","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/ana.24009","volume":"74","author":"Hauser","year":"2013","unstructured":"Hauser SL, Chan JR, Oksenberg JR (2013) Multiple sclerosis: prospects and promise. Ann Neurol 74:317\u2013327. doi:10.1002\/ana.24009","journal-title":"Ann Neurol"},{"key":"4305_CR6","doi-asserted-by":"crossref","unstructured":"Fox RJ, Rudick RA (2012) Risk stratification and patient counseling for natalizumab in multiple sclerosis. Neurology. 78(6):436\u2013437. doi:10.1212\/WNL.0b013e318245d2d0","DOI":"10.1212\/WNL.0b013e318245d2d0"},{"key":"4305_CR7","doi-asserted-by":"crossref","unstructured":"Tuohy O, Costelloe L, Hill-Cawthorne G et al (2014) Alemtuzumab treatment of multiple sclerosis: long-term safety and efficacy. J Neurol Neurosurg Psychiatry. doi:10.1136\/jnnp-2014-307721","DOI":"10.1136\/jnnp-2014-307721"},{"key":"4305_CR8","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/bmt.2011.185","volume":"47","author":"Snowden","year":"2012","unstructured":"Snowden J, Saccardi R, Allez M et al (2012) Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 47:770\u2013790. doi:10.1038\/bmt.2011.185","journal-title":"Bone Marrow Transplant"},{"key":"4305_CR9","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1212\/WNL.33.3_Suppl_1.14","volume":"33","author":"Kurtzke","year":"1983","unstructured":"Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:14\u201344","journal-title":"Neurology"},{"key":"4305_CR10","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1212\/WNL.0b013e3181dbb571","volume":"74","author":"Polman","year":"2010","unstructured":"Polman CH, Rudick R (2010) The multiple sclerosis functional composite: a clinically meaningful measure of disability. Neurology 74:S8\u2013S15","journal-title":"Neurology"},{"key":"4305_CR11","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s002770050527","volume":"78","author":"Waller","year":"1999","unstructured":"Waller CF, Fetscher S, Lange W (1999) Treatment-related chronic myelogenous leukemia. Ann Hematol 78:341\u2013354","journal-title":"Ann Hematol"},{"key":"4305_CR12","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3324\/haematol.2009.013458","volume":"95","author":"Farge","year":"2010","unstructured":"Farge D, Labopin M, Tyndall A et al (2010) Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years\u2018 experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases. Haematologica 95:284\u2013292. doi:10.3324\/haematol.2009.013458","journal-title":"Haematologica"},{"key":"4305_CR13","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1038\/bmt.2010.168","volume":"45","author":"Atkins","year":"2010","unstructured":"Atkins H (2010) Hematopoietic SCT for the treatment of multiple sclerosis. Bone Marrow Transplant 45:1671\u20131681. doi:10.1038\/bmt.2010.168","journal-title":"Bone Marrow Transplant"},{"key":"4305_CR14","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.bbmt.2012.06.003","volume":"18","author":"Pasquini","year":"2012","unstructured":"Pasquini MC, Voltarelli J, Atkins HL et al (2012) Transplantation for autoimmune diseases in north and South America: a report of the Center for International Blood and Marrow Transplant Research. Biol Blood Marrow Transplant 18:1471\u20131478. doi:10.1016\/j.bbmt.2012.06.003","journal-title":"Biol Blood Marrow Transplant"},{"key":"4305_CR15","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/pr.2011.57","volume":"71","author":"Daikeler","year":"2012","unstructured":"Daikeler T, Tichelli A, Passweg J (2012) Complications of autologous hematopoietic stem cell transplantation for patients with autoimmune diseases. Pediatr Res 71:439\u2013444. doi:10.1038\/pr.2011.57","journal-title":"Pediatr Res"},{"key":"4305_CR16","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/sj.bjc.6690718","volume":"81","author":"Harrison","year":"1999","unstructured":"Harrison C, Gregory W (1999) High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin\u2019s disease is unlikely to be associated with a major increased risk of secondary MDS\/AML. Br J Cancer 81:476\u2013483","journal-title":"Br J Cancer"},{"key":"4305_CR17","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S1474-4422(09)70017-1","volume":"8","author":"Burt","year":"2009","unstructured":"Burt RK, Loh Y, Cohen B et al (2009) Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I\/II study. Lancet Neurol 8:244\u2013253. doi:10.1016\/S1474-4422(09)70017-1","journal-title":"Lancet Neurol"},{"key":"4305_CR18","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1177\/1352458511429320","volume":"18","author":"Mancardi","year":"2012","unstructured":"Mancardi GL, Sormani MP, Di Gioia M et al (2012) Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: the Italian multi-centre experience. Mult Scler 18:835\u2013842. doi:10.1177\/1352458511429320","journal-title":"Mult Scler"},{"key":"4305_CR19","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.exphem.2012.07.003","volume":"40","author":"Shevchenko","year":"2012","unstructured":"Shevchenko JL, Kuznetsov AN, Ionova TI et al (2012) Autologous hematopoietic stem cell transplantation with reduced-intensity conditioning in multiple sclerosis. Exp Hematol 40(11):892\u2013898. doi:10.1016\/j.exphem.2012.07.003","journal-title":"Exp Hematol"},{"key":"4305_CR20","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1212\/WNL.0b013e318211c537","volume":"76","author":"Fassas","year":"2011","unstructured":"Fassas A, Kimiskidis VK, Sakellari I et al (2011) Long-term results of stem cell transplantation for MS: a single-center experience. Neurology 76:1066\u20131070. doi:10.1212\/WNL.0b013e318211c537","journal-title":"Neurology"},{"key":"4305_CR21","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1136\/jnnp-2013-307207","volume":"85","author":"Burman","year":"2014","unstructured":"Burman J, Iacobaeus E, Svenningsson A et al (2014) Autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: the Swedish experience. J Neurol Neurosurg Psychiatry 85:1116\u20131121. doi:10.1136\/jnnp-2013-307207","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4305_CR22","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1001\/jamaneurol.2014.3780","volume":"72","author":"Nash","year":"2015","unstructured":"Nash RA, Hutton GJ, Racke MK et al (2015) High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for relapsing-remitting multiple sclerosis (HALT-MS). JAMA Neurol 72:159\u2013169. doi:10.1001\/jamaneurol.2014.3780","journal-title":"JAMA Neurol"},{"key":"4305_CR23","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1182\/blood.V91.7.2609","volume":"91","author":"Burt","year":"1998","unstructured":"Burt R, Padilla J (1998) Effect of disease stage on clinical outcome after syngeneic bone marrow transplantation for relapsing experimental autoimmune encephalomyelitis. Blood 91:2609\u20132616","journal-title":"Blood"},{"key":"4305_CR24","first-page":"177","volume":"29","author":"Meng","year":"2011","unstructured":"Meng L, Ouyang J, Zhang H et al (2011) Treatment of an autoimmune encephalomyelitis mouse model with nonmyeloablative conditioning and syngeneic bone marrow transplantation. Restor Neurol Neurosci 29:177\u2013185. doi:10.3233\/RNN-2011-0590","journal-title":"Restor Neurol Neurosci"},{"key":"4305_CR25","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1093\/brain\/awt182","volume":"136","author":"Abrahamsson","year":"2013","unstructured":"Abrahamsson SV, Angelini DF, Dubinsky AN et al (2013) Non-myeloablative autologous haematopoietic stem cell transplantation expands regulatory cells and depletes IL-17 producing mucosal-associated invariant T cells in multiple sclerosis. Brain 136:2888\u20132903. doi:10.1093\/brain\/awt182","journal-title":"Brain"},{"key":"4305_CR26","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1084\/jem.20041679","volume":"201","author":"Muraro","year":"2005","unstructured":"Muraro P, Douek DC, Packer A et al (2005) Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients. J Exp Med 201:805\u2013816. doi:10.1084\/jem.20041679","journal-title":"J Exp Med"},{"key":"4305_CR27","doi-asserted-by":"crossref","unstructured":"Burman J, Frans M, Thomas HT et al (2013) T-cell responses after haematopoietic stem cell transplantation for aggressive relapsing \u2013 remitting multiple sclerosis. Immunology 140. doi:10.1111\/imm.12129","DOI":"10.1111\/imm.12129"},{"key":"4305_CR28","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1172\/JCI71691","volume":"124","author":"Muraro","year":"2014","unstructured":"Muraro P, Robins H, Malhotra S et al (2014) T cell repertoire following autologous stem cell transplantation for multiple sclerosis. J Clin Invest 124:1168\u20131172. doi:10.1172\/JCI71691DS1","journal-title":"J Clin Invest"},{"key":"4305_CR29","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1056\/NEJM198612253152603","volume":"315","author":"Ebers","year":"1986","unstructured":"Ebers GC, Bulman DE, Sadovnick AD et al (1986) A population-based study of multiple sclerosis in twins. N Engl J Med 315:1638\u20131642","journal-title":"N Engl J Med"},{"key":"4305_CR30","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1001\/jamaneurol.2013.5486","volume":"71","author":"Bevan","year":"2014","unstructured":"Bevan C, Cree B (2014) Disease activity free status: a new end point for a new era in multiple sclerosis clinical research? JAMA Neurol 71:269\u2013270. doi:10.1001\/jamaneurol.2013.5486.Conflict","journal-title":"JAMA Neurol"},{"key":"4305_CR31","doi-asserted-by":"crossref","unstructured":"Coles AJ, Twyman CL, Arnold DL et al (2012) Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial. Lancet 1829\u20131839. doi:10.1016\/S0140-6736(12)61768-1","DOI":"10.1016\/S0140-6736(12)61768-1"},{"key":"4305_CR32","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1212\/01.wnl.0000313034.46883.16","volume":"71","author":"Ebers","year":"2008","unstructured":"Ebers GC, Heigenhauser L, Daumer M et al (2008) Disability as an outcome in MS clinical trials. Neurology 71: 624\u2013631. doi:10.1212\/01.wnl.0000313034.46883.16","journal-title":"Neurology"},{"key":"4305_CR33","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.3174\/ajnr.A0644","volume":"28","author":"Rocca","year":"2007","unstructured":"Rocca MA, Mondria T, Valsasina P et al (2007) A three-year study of brain atrophy after autologous hematopoietic stem cell transplantation in rapidly evolving secondary progressive multiple sclerosis. Am J Neuroradiol 28:1659\u20131661. doi:10.3174\/ajnr.A0644","journal-title":"Am J Neuroradiol"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-015-4305-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00115-015-4305-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-015-4305-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T23:32:31Z","timestamp":1599003151000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00115-015-4305-x"}},"subtitle":["Hamburger Erfahrungen und internationaler Forschungsstand"],"short-title":[],"issued":{"date-parts":[[2015,5,10]]},"references-count":33,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["4305"],"URL":"https:\/\/doi.org\/10.1007\/s00115-015-4305-x","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,10]]}}}